Pretreatment with stress cortisol enhances the human systemic inflammatory response to bacterial endotoxin

Critical Care Medicine

Volumn 37, Issue 10, 2009, Pages 2727-2732

  Yeager, Mark P ^a   Rassias, Athos J ^a   Pioli, Patricia A ^a   Beach, Michael L ^b   Wardwell, Kathleen ^a   Collins, Jane E ^a   Lee, Hong Kee ^a   Guyre, Paul M ^c  

^a Department of Anesthesiology and Medicine ^*

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Cytokine; Experimental endotoxemia; Glucocorticoid; Human; Interleukin 6; Sepsis

Indexed keywords

CYTOKINE; ENDOTOXIN; HYDROCORTISONE SODIUM SUCCINATE; INTERLEUKIN 10; INTERLEUKIN 6; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOTOXEMIA; ESCHERICHIA COLI; EXPERIMENTAL MODEL; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; IN VIVO STUDY; INFLAMMATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STRESS;

EID: 70349659445     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181a592b3     Document Type: Article

References (58)

1. Hench P, Kendall E, Slocumb C, et al: The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis; preliminary report. Proc Staff Meet Mayo Clin 1949; 24:181-197
2. Selye H: Role of the hypophysis in the pathogenesis of the diseases of adaption. Can Med Assoc J 1944; 50:426-433
3. Selye H, Dosne C, Bassett L, et al: On the therapeutic value of adrenal cortical hormones in traumatic shock and allied conditions. Can Med Assoc J 1940; 43:1-8
4. Ingle D: The role of the adrenal cortex in homeostasis. J Endocrinol 1952; 8:23-37
5. Yeager MP, Guyre PM, Munck AU: Glucocorticoid regulation of the inflammatory response to injury. Acta Anaesthesiol Scand 2004; 48:799-813
6. Shieh J-H, Peterson RH, Moore MA: Cytokines and dexamethasone modulation of IL-1 receptors on human neutrophils in vitro. J Immunol 1993; 150:3515-3524
7. Wiegers GJ, Labeur M, Stec I, et al: Glucocorticoids accelerate anti-T cell receptorinduced T cell growth. J Immunol 1995; 155: 1893-1902
8. Paterson RK, Or R, Domenico J, et al: Regulation of CD23 expression by IL-4 and corti- costeroid in human B lymphocytes. J Immunol 1994; 152:2139-2147
9. Pietzko D, Zohlnhofer D, Graeve L, et al: The hepatic interleukin-6 receptor. J Biol Chem 1993; 268:4250-4258
10. Franchimont D, Galon J, Vacchio MS, et al: Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor . J Immunol 2002; 168:2212-2218
11. Strickland RW, Wahl LM, Finblood DS: Corticoid steroids enhance the binding of recombinant interferon-V to cultured human monocytes. J Immunol 1986; 137:1577-1580
12. Hawrylowicz C, Guida L, Paleolog E: Dexamethasone up-regulates granulocyte-macrophage colony- stimulating factor receptor expression on human monocytes. Immunology 1994; 83: 274-280
13. van der Goes A, Hoekstra K, van den Berg TK, et al: Dexamethasone promotes phagocytosis and bacterial killing by human monocytes/ macrophages in vitro. J Leukoc Biol 2000; 67:801-807
14. Freischlag J, Colburn M, Quinones-Baldrich M, et al: Alteration of neutrophil (PMN) function by heparin, dexamethasone, and enalapril. J Surg Res 1992; 52:523-529
15. Lloberas J, Soler C, Celada A: Dexamethasone enhances macrophage colony stimulating factor- and granulocyte macrophage colony stimulating factor-stimulated proliferation of bone marrow-derived macrophages. Int Immunol 1998; 10:593-599
16. Dinkel K, MacPherson A, Sapolsky RM: Novel glucocorticoid effects on acute inflammation in the CNS. J Neurochem 2003; 84:705-716
17. Munck A, Guyre P: Glucocorticoid physiology, pharmacology and stress. Adv Exp Med Biol 1986; 196:81-96
18. Munck A, Guyre P, Holbrook N: Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984; 5:25-44
19. Sapolsky RM, Romero M, Munck AU: How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000; 21:55-89
20. Guyre P, Yeager M, Munck A: Glucocorticoid effects on immune responses. Neuroimmune Biology 2008; 7:147-168
21. Lim H-Y, Müller N, Herold M, et al: Glucocorticoids exert opposing effects on macrophage function dependent on their concentration. Immunology 2007; 122:47-53
22. Calandra T, Bucala R: Macrophage migration inhibitory factor (MIF): A glucocorticoid counter-regulator within the immune system. Crit Rev Immunol 1997; 17:77-88
23. Yeager M, Pioli P, Wardwell K, et al: In vivo exposure to high or low cortisol has bi-phasic effects on inflammatory response pathways of human monocytes. Anesth Analg 2008; 107:1726-1734
24. Warren M, Vogel S: Opposing effects of glucocorticoids on interferon-γ-induced murine macrophage Fc receptor and Ia antigen expression. J Immunol 1985; 134:2462-2469
25. Eastman H, Fawcett T, Udelsman R, et al: Effects of perturbations of the hypothalamic- pituitary-adrenal axis on the acute phase response: Altered C/EBP and acute phase response gene expression in lipopolysaccharidetreated rats. Shock 1996; 6:286-292
26. Dhabhar FS, McEwen BS: Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci USA 1999; 96:1059-1064
27. Matsusue S, Walser M: Healing of intestinal anastomoses in adrenalectomized rats given corticosterone. Am J Physiol 1992; 263: R164-R168
28. Barber AE, Coyle SM, Marano MA, et al: Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 1993; 150:1999-2006
29. Smyth GP, Stapleton PP, Freeman TA, et al: Glucocorticoid pretreatment induces cytokine overexpression and nuclear factorkappaB activation in macrophages. J Surg Res 2004; 116:253-261
30. Maung A, Fujimi S, MacConmara M, et al: Injury enhances resistance to Escherichia coli infection by boosting innate immune system function. J Immunol 2008; 180:2450-2458
31. Kallapur S, Kramer B, Moss TJM: Maternal glucocorticoids increase endotoxin-induced lung inflammation in preterm lambs. Am J Physiol Lung Cell Mol Physiol 2003; 284: L633-L642
32. de Kruif MD, Lemaire LC, Giebelen IA, et al: Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia. J Immunol 2007; 178:1845-1851
33. Hardin J, Hilbe J: Generalized Estimating Equations. New York, Chapman & Hall, 2003
34. Rassias AJ, Holzberger PT, Givan AL, et al: Decreased physiologic variability as a generalized response to human endotoxemia. Crit Care Med 2005; 33:512-519
35. Schreiber W, Pollmacher T, Fassbender K, et al: Endotoxin- and corticotropin-releasing hormone-induced release of ACTH and cortisol. Neuroendocrinology 1993; 58:123-128
36. Gabay C: Proceedings: Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006, 8(suppl 2):1-6
37. Cooper MS, Stewart PM: Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003; 348:727-734
38. Yeager MP, Rassias AJ, Fillinger MP, et al: Cortisol antiinflammatory effects are maximal at postoperative plasma concentrations. Crit Care Med 2005; 33:1507-1512
39. Fantuzzi G, Galli G, Zinetti M, et al: The upregulating effect of dexamethasone on tumor necrosis factor production is mediated by a nitric oxide-producing cytochrome P450. Cell Immunol 1995; 160:305-308
40. Dhabhar FS: Stress-induced augmentation of immune function-The role of stress hormones, leukocyte trafficking, and cytokines. Brain Behav Immun 2002; 16:785-798
41. Bendel S, Karlsson S, Pettila V: Free cortisol in sepsis and septic shock. Anesth Analg 2008; 106:1813-1819
42. Shipman GF, Bloomfield CD, Gajl-Peczalska K, et al: Glucocorticoids and lymphocytes. III. Effects of glucocorticoid administration on lymphocyte glucocorticoid receptors. Blood 1983; 61:1086-1090
43. Burnstein K, Bellingham D, Jewell C, et al: Autoregulation of glucocorticoid receptor gene expression. Steroids 1991; 56:52-58
44. Lauw F, Pajkrt D, Hack C, et al: Proinflammatory effects of IL-10 during human endotoxemia. J Immunol 2000; 165:2783-2789
45. Pajkrt D, Camoglio L, Tiel-van Buul MC, et al: Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: Effect of timing of recombinant human IL-10 administration. J Immunol 1997; 158:3971-3977
46. Wiegers GJ, Reul JMHM: Induction of cytokine receptors by glucocorticoids: Functional and pathological significance. TiPS 1998; 19:317-321
47. Spriggs MK, Lioubin PJ, Slack J, et al: Induction of an interleukin-1 receptor (IL-1R) on monocytic cells. J Biol Chem 1990; 265: 22499-22505
48. Snyers L, DeWitt L, Content J: Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells. Proc Natl Acad Sci USA 1990; 87:2838-2842
49. Fantuzzi G, Demitri MT, Ghezzi P: Differential effect of glucocorticoids on tumour necrosis factor production in mice: Up-regulation by early pretreatment with dexamethasone. Clin Exp Immunol 1994; 96:166-169
50. Honkakoski P, Negishi M: Regulation of cytochrome p450 (CYP) genes by nuclear receptors. Biochem J 2000; 347:321-337
51. Paterson H, Murphy T, Purcell E, et al: Injury primes the innate immune system for enhanced toll-like receptor reactivity. J Immunol 2003; 171:1473-1483
52. Zhang TY, Daynes RA: Glucocorticoid conditioning of myeloid progenitors enhances TLR4 signaling via negative regulation of the phosphatidylinositol 3-kinase-Akt pathway. J Immunol 2007; 178:2517-2526
53. Lang R, Hammer M, Mages J: DUSP meet immunology: Dual specificity MAPK phosphatases in control of the inflammatory response. J Immunol 2006; 177:7497-7504
54. Horwood NJ, Page TH, McDaid JP, et al: Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production. J Immunol 2006; 176:3635-3641
55. Zhao W, Liu M, Kirkwood KL: p38alpha stabilizes interleukin-6 mRNA via multiple AUrich elements. J Biol Chem 2008; 283: 1778-1785
56. Jeffrey KL, Camps M, Rommel C, et al: Targeting dual-specificity phosphatases: Manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov 2007; 6:391-403
57. Marshall J: Sepsis: Rethinking the approach to clinical research. J Leukocyte Biol 2008; 83:471-482
58. Lowry SF: Human endotoxemia: A model for mechanistic insight and therapeutic targeting. Shock 2005; 24(suppl 1):94-100